2 transactions on file, per SEC Form 4 filings.
Enguent Jean-Pierre
Vice President, R&DSS · 2026-09-03
Sold
$36K
Enguent Jean-Pierre
Vice President, R&DSS · 2026-09-01
Option exercise
$0K
Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.
Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.
Analyze LAES